Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Profound Medical (TSE:PRN)
TSX:PRN
Profound Medical (PRN) Stock Price & Analysis
70 Followers
PRN Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$9.55 - C$17.02
Previous CloseC$13.9
Volume10.41K
Average Volume (3M)6.14K
Market Cap
C$339.56M
Enterprise ValueC$314.40M
Total Cash (Recent Filing)$26.21M
Total Debt (Recent Filing)$7.94M
Price to Earnings (P/E)―
Beta0.52
Next Earnings
Aug 08, 2024EPS Estimate
-C$0.38Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.73
Shares Outstanding24,428,899
10 Day Avg. Volume6,244
30 Day Avg. Volume6,140
Standard Deviation0.24
R-Squared0.02
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)7.11
Price to Sales (P/S)41.11
Price to Cash Flow (P/CF)-7.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue43.67
Enterprise Value/Gross Profit71.75
Enterprise Value/Ebitda-11.68
Forecast
1Y Price Target
C$16.53Price Target Upside18.92% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Profound Medical News
PremiumCompany Announcements
Profound Medical Unveils Q2 2024 Financials
PremiumCompany Announcements
Profound Medical Raises US$2.93M in Private PlacementPRN FAQ
What was Profound Medical’s price range in the past 12 months?
Profound Medical lowest stock price was C$9.55 and its highest was C$17.02 in the past 12 months.
What is Profound Medical’s market cap?
Currently, no data Available
When is Profound Medical’s upcoming earnings report date?
Profound Medical’s upcoming earnings report date is Aug 08, 2024 which is in 15 days.
How were Profound Medical’s earnings last quarter?
Profound Medical released its earnings results on May 09, 2024. The company reported -C$0.358 earnings per share for the quarter, beating the consensus estimate of -C$0.41 by C$0.052.
Is Profound Medical overvalued?
According to Wall Street analysts Profound Medical’s price is currently Undervalued.
Does Profound Medical pay dividends?
Profound Medical does not currently pay dividends.
What is Profound Medical’s EPS estimate?
Profound Medical’s EPS estimate is -C$0.38.
How many shares outstanding does Profound Medical have?
Profound Medical has 24,428,900 shares outstanding.
What happened to Profound Medical’s price movement after its last earnings report?
Profound Medical reported an EPS of -C$0.358 in its last earnings report, beating expectations of -C$0.41. Following the earnings report the stock price went down -9.278%.
Which hedge fund is a major shareholder of Profound Medical?
Currently, no hedge funds are holding shares in TSE:PRN
---
Profound Medical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$16.53 (18.92% Upside)
C$16.53 (18.92% Upside)
Blogger Sentiment
Bullish
TSE:PRN Sentiment 100%
Sector Average 72%
Sector Average 72%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-17.70%
12-Months-Change
Fundamentals
Return on Equity
-59.11%
Trailing 12-Months
Asset Growth
-6.31%
Trailing 12-Months
Company Description
Profound Medical
Profound Medical Corp is a medical technology company. It provides incision-free therapies that combine real-time Magnetic Resonance (MR) imaging, thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased tissue. The company develops a treatment to ablate the prostate gland in prostate cancer patients.
---
PRN Stock 12 Month Forecast
Average Price Target
C$16.53
▲(18.92% Upside)
Technical Analysis
Best Analysts Covering PRN
1 Year
1 Year Success Rate
15/29 ratings generated profit
1 Year Average Return
+19.42%
reiterated a buy rating 10 months ago
Copying Rahul Sarugaser's trades and holding each position for 1 Year would result in 51.72% of your transactions generating a profit, with an average return of +19.42% per trade.
---